Home/Filings/4/0001012975-18-001198

4//SEC Filing

ARCH Venture Partners VIII, LLC 4

Accession 0001012975-18-001198

CIK 0001581280other

View on SEC.gov Company Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 4:31 PM ET

Size

37.1 KB

Accession

0001012975-18-001198

Insider Transaction Report

Form 4

Period: 2018-11-02

Twist Bioscience CorpTWST

ARCH Venture Partners VIII, LLC

10% Owner

Transactions

Purchase
Common Stock
2018-11-02$14.00/sh+15,000$210,000→ 2,407,422 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+894,146→ 894,146 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+266,776→ 2,167,696 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+224,726→ 2,392,422 total(indirect: See footnote)
Conversion
Series A Preferred Stock
2018-11-02−1,182,645→ 0 total(indirect: See footnote)
→ Common Stock (1,182,645 underlying)
Conversion
Common Stock
2018-11-02+1,182,645→ 1,182,645 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+718,275→ 1,900,920 total(indirect: See footnote)
Conversion
Series C Preferred Stock
2018-11-02−266,776→ 0 total(indirect: See footnote)
→ Common Stock (266,776 underlying)
Purchase
Common Stock
2018-11-02$14.00/sh+60,000$840,000→ 954,146 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2018-11-02−718,275→ 0 total(indirect: See footnote)
→ Common Stock (718,275 underlying)
Conversion
Series D Preferred Stock
2018-11-02−224,726→ 0 total(indirect: See footnote)
→ Common Stock (224,726 underlying)
Conversion
Series D Preferred Stock
2018-11-02−894,146→ 0 total(indirect: See footnote)
→ Common Stock (894,146 underlying)

ARCH Venture Partners VII, L.P.

10% Owner

Transactions

Conversion
Series A Preferred Stock
2018-11-02−1,182,645→ 0 total(indirect: See footnote)
→ Common Stock (1,182,645 underlying)
Conversion
Common Stock
2018-11-02+1,182,645→ 1,182,645 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+266,776→ 2,167,696 total(indirect: See footnote)
Conversion
Series C Preferred Stock
2018-11-02−266,776→ 0 total(indirect: See footnote)
→ Common Stock (266,776 underlying)
Conversion
Series D Preferred Stock
2018-11-02−224,726→ 0 total(indirect: See footnote)
→ Common Stock (224,726 underlying)
Conversion
Common Stock
2018-11-02+718,275→ 1,900,920 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+224,726→ 2,392,422 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+15,000$210,000→ 2,407,422 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+60,000$840,000→ 954,146 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2018-11-02−718,275→ 0 total(indirect: See footnote)
→ Common Stock (718,275 underlying)
Conversion
Series D Preferred Stock
2018-11-02−894,146→ 0 total(indirect: See footnote)
→ Common Stock (894,146 underlying)
Conversion
Common Stock
2018-11-02+894,146→ 894,146 total(indirect: See footnote)

Arch Venture Fund VII LP

10% Owner

Transactions

Conversion
Common Stock
2018-11-02+1,182,645→ 1,182,645 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2018-11-02−718,275→ 0 total(indirect: See footnote)
→ Common Stock (718,275 underlying)
Conversion
Series D Preferred Stock
2018-11-02−894,146→ 0 total(indirect: See footnote)
→ Common Stock (894,146 underlying)
Purchase
Common Stock
2018-11-02$14.00/sh+60,000$840,000→ 954,146 total(indirect: See footnote)
Conversion
Series C Preferred Stock
2018-11-02−266,776→ 0 total(indirect: See footnote)
→ Common Stock (266,776 underlying)
Conversion
Common Stock
2018-11-02+266,776→ 2,167,696 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+15,000$210,000→ 2,407,422 total(indirect: See footnote)
Conversion
Series D Preferred Stock
2018-11-02−224,726→ 0 total(indirect: See footnote)
→ Common Stock (224,726 underlying)
Conversion
Common Stock
2018-11-02+718,275→ 1,900,920 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+224,726→ 2,392,422 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+894,146→ 894,146 total(indirect: See footnote)
Conversion
Series A Preferred Stock
2018-11-02−1,182,645→ 0 total(indirect: See footnote)
→ Common Stock (1,182,645 underlying)

ARCH Venture Fund VIII Overage, L.P.

10% Owner

Transactions

Conversion
Series D Preferred Stock
2018-11-02−894,146→ 0 total(indirect: See footnote)
→ Common Stock (894,146 underlying)
Conversion
Common Stock
2018-11-02+718,275→ 1,900,920 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+224,726→ 2,392,422 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+15,000$210,000→ 2,407,422 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+894,146→ 894,146 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+60,000$840,000→ 954,146 total(indirect: See footnote)
Conversion
Series D Preferred Stock
2018-11-02−224,726→ 0 total(indirect: See footnote)
→ Common Stock (224,726 underlying)
Conversion
Common Stock
2018-11-02+1,182,645→ 1,182,645 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+266,776→ 2,167,696 total(indirect: See footnote)
Conversion
Series A Preferred Stock
2018-11-02−1,182,645→ 0 total(indirect: See footnote)
→ Common Stock (1,182,645 underlying)
Conversion
Series B Preferred Stock
2018-11-02−718,275→ 0 total(indirect: See footnote)
→ Common Stock (718,275 underlying)
Conversion
Series C Preferred Stock
2018-11-02−266,776→ 0 total(indirect: See footnote)
→ Common Stock (266,776 underlying)

ARCH Venture Partners VII, LLC

10% Owner

Transactions

Conversion
Series D Preferred Stock
2018-11-02−224,726→ 0 total(indirect: See footnote)
→ Common Stock (224,726 underlying)
Conversion
Common Stock
2018-11-02+1,182,645→ 1,182,645 total(indirect: See footnote)
Conversion
Series A Preferred Stock
2018-11-02−1,182,645→ 0 total(indirect: See footnote)
→ Common Stock (1,182,645 underlying)
Conversion
Series D Preferred Stock
2018-11-02−894,146→ 0 total(indirect: See footnote)
→ Common Stock (894,146 underlying)
Conversion
Common Stock
2018-11-02+718,275→ 1,900,920 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+266,776→ 2,167,696 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+224,726→ 2,392,422 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+15,000$210,000→ 2,407,422 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+894,146→ 894,146 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+60,000$840,000→ 954,146 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2018-11-02−718,275→ 0 total(indirect: See footnote)
→ Common Stock (718,275 underlying)
Conversion
Series C Preferred Stock
2018-11-02−266,776→ 0 total(indirect: See footnote)
→ Common Stock (266,776 underlying)

BYBEE CLINTON

10% Owner

Transactions

Conversion
Common Stock
2018-11-02+1,182,645→ 1,182,645 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+718,275→ 1,900,920 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2018-11-02−718,275→ 0 total(indirect: See footnote)
→ Common Stock (718,275 underlying)
Conversion
Series D Preferred Stock
2018-11-02−894,146→ 0 total(indirect: See footnote)
→ Common Stock (894,146 underlying)
Conversion
Common Stock
2018-11-02+224,726→ 2,392,422 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+894,146→ 894,146 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+60,000$840,000→ 954,146 total(indirect: See footnote)
Conversion
Series C Preferred Stock
2018-11-02−266,776→ 0 total(indirect: See footnote)
→ Common Stock (266,776 underlying)
Conversion
Common Stock
2018-11-02+266,776→ 2,167,696 total(indirect: See footnote)
Conversion
Series A Preferred Stock
2018-11-02−1,182,645→ 0 total(indirect: See footnote)
→ Common Stock (1,182,645 underlying)
Conversion
Series D Preferred Stock
2018-11-02−224,726→ 0 total(indirect: See footnote)
→ Common Stock (224,726 underlying)
Purchase
Common Stock
2018-11-02$14.00/sh+15,000$210,000→ 2,407,422 total(indirect: See footnote)

NELSEN ROBERT

10% Owner

Transactions

Conversion
Common Stock
2018-11-02+1,182,645→ 1,182,645 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+266,776→ 2,167,696 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+15,000$210,000→ 2,407,422 total(indirect: See footnote)
Purchase
Common Stock
2018-11-02$14.00/sh+60,000$840,000→ 954,146 total(indirect: See footnote)
Conversion
Series C Preferred Stock
2018-11-02−266,776→ 0 total(indirect: See footnote)
→ Common Stock (266,776 underlying)
Conversion
Series A Preferred Stock
2018-11-02−1,182,645→ 0 total(indirect: See footnote)
→ Common Stock (1,182,645 underlying)
Conversion
Common Stock
2018-11-02+224,726→ 2,392,422 total(indirect: See footnote)
Conversion
Series B Preferred Stock
2018-11-02−718,275→ 0 total(indirect: See footnote)
→ Common Stock (718,275 underlying)
Conversion
Series D Preferred Stock
2018-11-02−224,726→ 0 total(indirect: See footnote)
→ Common Stock (224,726 underlying)
Conversion
Series D Preferred Stock
2018-11-02−894,146→ 0 total(indirect: See footnote)
→ Common Stock (894,146 underlying)
Conversion
Common Stock
2018-11-02+718,275→ 1,900,920 total(indirect: See footnote)
Conversion
Common Stock
2018-11-02+894,146→ 894,146 total(indirect: See footnote)

Footnotes (6)

[F1]Upon closing of the Issuer's initial public offering, each share of preferred stock was automatically converted into one share of the Issuer's common stock, for no additional consideration, on a 1:1 basis.
[F2]The shares are directly held by ARCH Venture Fund VII, L.P. ("ARCH Fund VII"). The sole general partner of ARCH Fund VII is ARCH Venture Partners VII, L.P. ("ARCH Partners VII"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. The sole general partner of ARCH Partners VII is ARCH Venture Partners VII, LLC ("ARCH VII LLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Fund VII. ARCH Partners VII and ARCH VII LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
[F3]Clinton Bybee and Robert Nelsen are the managing directors of ARCH VII LLC and ARCH VIII LLC, and they may be deemed to beneficially own the shares held by ARCH Fund VII and ARCH Overage. Messrs. Bybee and Nelsen disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
[F4]Reflects shares purchased in the Issuer's initial public offering.
[F5]The shares are directly held by ARCH Venture Fund VIII Overage, L.P. ("ARCH Overage"). The sole general partner of ARCH Overage is ARCH Venture Partners VIII, LLC ("AVP GPLLC"), which may be deemed to be the beneficial owner of the shares held by ARCH Overage. AVP GPLLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
[F6]The expiration date is not relevant to the conversion of these securities.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Twist Bioscience Corp

CIK 0001581280

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001616165

Filing Metadata

Form type: 4
Filed: Nov 5, 7:00 PM ET
Accepted: Nov 6, 4:31 PM ET
Size: 37.1 KB

View on SEC.gov